/Companies

IDRx

3 known investors

Find your way into IDRx

Sign up to see every warm intro you have to IDRx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the IDRx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases. The company aims to positively impact the health of 2.5 billion people by the end of the decade.

Founders & leadership

TCTim Clackson
Tim ClacksonA biotech executive whose leadership roles include President and CEO of Theseus Pharmaceuticals and President and Chief Technology Officer at Xilio Therapeutics. He has served on the boards of Elevation Oncology, Forma Therapeutics, MassBio, Kesmalea Therapeutics, and PanTher Therapeutics.

Investors · 3

Funding

SEC filings, press & company announcements

$120M disclosed across 1 of 4 rounds · 2022–2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does IDRx do?
IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases. The company aims to positively impact the health of 2.5 billion people by the end of the decade.
Who are IDRx's investors?
IDRx's investors include Andreessen Horowitz, Nextech Invest, RA Capital.
How much funding has IDRx raised?
IDRx has disclosed $120M raised across 1 of its 4 known rounds.